Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
mRNA- and adenovirus vector-based vaccines have been successfully developed and used in clinical practice against SARS-CoV-2, the pathogen that caused the COVID-19 pandemic. These vaccines were highly effective, inducing robust humoral and cellular …